MetLife Inc. (NYSE:MET) saw an upside of 0.20% to close Monday at $65.12 after adding $0.13 on the day. The 5-day average trading volume is 4,657,440 shares of the company’s common stock. It has gained $66.12 in the past week. An average of 5,344,960 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 4,666,104.
MET’s 1-month performance is 7.16% or $4.35 on its low of $58.14 reached on 09/21/21. The company’s shares have touched a 52-week low of $35.90 and high of $67.68, with the stock’s rally to the 52-week high happening on 05/10/21. YTD, MET has achieved 38.70% or $18.17. However, the current price is down -3.78%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
On May 19, 146 days have gone by since the last insider trading activity for MetLife Inc. (MET). Lee Esther (EVP – Gl. Chief Marketing Off.) most recently sold 7,800 shares at $64.76 per share on May 19. This transaction cost the insider $505,166. EVP & Chief Risk Officer, DEBEL MARLENE, sold 11,000 shares at a price of $64.58 on May 11. Then, on Feb 24, EVP & Chief Financial Officer McCallion John D. sold 7,742 shares at a price of $59.52 per share. This transaction amounted to $460,776.
The company’s PE ratio for the last five years has touched a high of 324.69 and a low of 2.950. MET stock has a beta of 1.30. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.80 while the price-to-book (PB) in the most recent quarter is 0.82, with the price to cash flow ratio at 5.02.
It is projected that MetLife Inc.’s next ex-dividend date will be on 5-Nov. MET is expected to distribute $0.48 as its next dividend.
As well, the company’s long term debt to equity for the quarter ending June 29 was 0.26, while the total debt to equity was 0.26 while for the period ending June 29; MetLife Inc.’s operating margin was 9.80%. The firm’s gross profit as reported stood at $6.93 billion against revenue of $67.84 billion.
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Analysts expected MET to announce $1.62 per share in earnings in its latest quarter, but it posted $2.37, representing a 46.30% surprise. EBITDA for the quarter stood at more than $4.49 billion. MET stock balance sheet for the quarter ending June 29 shows that, with total debt at $109.64 billion. Shareholders hold equity totaling $856.9 million
Let’s look briefly at MetLife Inc. (MET) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 11 October was 68.79% to suggest the stock is trending Neutral, with historical volatility in this time period at 18.55%.
The stock’s 5-day moving average is $64.58, reflecting a +4.41% or $2.75 change from its current price. MET is currently trading +5.39% above its 20-day SMA, +0.45% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by +12.86% and +41.17% respectively.
Stochastic %K and %D was 91.51% and 92.92% and the average true range (ATR) pointed at 1.40. The RSI (14) points at 64.11%, while the 14-day stochastic is at 85.27% with the period’s ATR at 1.41. The stock’s 9-day MACD Oscillator is pointing at 1.32 and 1.99 on the 14-day charts.
In the most recent analyst report for MetLife Inc. (NYSE: MET), UBS launched coverage with a Buy rating. Analysts offering their rating for MET stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate MET as a “sell,”, while 2 advise that investors “Hold.” 1 analysts have rated the stock as underweight. 2 rates the stock as overweight while 10 have offered a “buy” rating.
What is MET’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $66.00 and a high of $77.00, with their median price target at $74.00. Looking at these predictions, the average price target given by analysts is for MetLife Inc. (MET) stock is $71.73.